Lonza shares soar - Lifts 2018 outlook as Capsugel integration ‘exceeded expectations’
Swiss pharmaceutical and nutritional ingredients maker has upgraded its growth targets for 2018 on the back of a better-than-expected integration of Capsugel and ‘buoyant demand’ in key areas.